Reinvent the Role of Corporate Counsel as Solution-Oriented, Value-Creating, Strategic Partners to a Cutting Edge, Innovation-Centric, Scientific Community

In-House Impact: Life Sciences is the only forum dedicated to legal leaders working within the life sciences industry.

It is a unique opportunity to gather with your peers in pharma, biotech and medical device in-house legal teams to collaborate and carve out a new narrative for the legal function – from enterprise defenders to integrated enablers of innovation.

The goal of In House Impact: Life Sciences is to focus on the soft skills necessary to excel in your role as an in-house legal leader that weren’t taught in law school.

Uncover how the most high-impact legal teams are embedding innovation, collaboration and creativity into their DNA, sharing exactly how that’s allowing them to move from minimizing risk to maximizing opportunity in operating as true partners to their rapidly growing scientific business and helping them get better drugs to patients faster.

Our 2022 speaker faculty includes:

Testimonials

'Most of us have access to a small number of fellow GCs we can reach out to for advice, but very few of us are part of a wider industry-specific community of GCs able to discuss  and debate the future of our legal function. This is why I’m excited to be a part of In-House Impact: Life Sciences, to enhance and facilitate  those invaluable relationships.'

Jonathan Biller, Chief Legal Officer, Agios Pharmaceuticals 

'Geared specifically towards General Counsels and their inhouse teams within Life Sciences, In-House Impact looks set  to occupy a unique and invaluable space in the industry.'

Marcela Kirberger, General Counsel & Secretary, Roche Diagnostics Corporation 

'In-House Impact: Life Sciences is a useful forum for in-house legal leaders to share practical experiences on how to best collaborate with other business partners to deliver and create value to employees, the organization and stockholders.'

Jason Okazaki, Chief Legal & Business Officer, Assembly Biosciences 

'Experiencing alone the journey from start-up to the rapid scaling of a fast-growth organization can be an intimidating process, but with this unique opportunity to engage with other GCs from across the Life Sciences, I’m excited to be a part of In-House Impact: Life Sciences, and discover what my peers are doing to find success through rapid change.'

Dina Ciarimboli, General Counsel, Third Rock Ventures 

Sponsors & Partners

Panel Partner

Expertise Partner

Exhibition Partner

Expertise Partner